Is ARCT a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Arcturus Therapeutics Holdings Inc (ARCT) is (97.13) USD. With the latest stock price at 12.88 USD, the upside of Arcturus Therapeutics Holdings Inc based on DCF is -854.1%. This means that ARCT is a sell according to the DCF valuation model.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 8.8% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (313.78) - (57.11) | (97.13) |
| Upside | -2536.2% - -543.4% | -854.1% |